CDC Global HIV and TB Participation at IAS 2023
The 12th IAS Conference on HIV Science (IAS 2023) will take place in Brisbane, Australia and virtually from July 23 – 26, 2023. This meeting is one of the world’s most influential forums for sharing HIV research and its application in the real world.
IAS 2023 will bring together scientists and influencers from around the world, including subject matter experts from CDC’s Division of Global HIV & TB to build momentum around latest developments in HIV-related research. CDC leaders, technical experts, and partners will present oral, poster, and late breaking abstracts highlighting their latest work to accelerate progress toward ending HIV.
CDC Global Research at IAS 2023
Several of the studies highlight how CDC is addressing the critical need to reach populations that continue to be left behind, such as adolescent girls and young women and key populations which include men who have sex with men, people who inject drugs, female sex workers, and incarcerated populations. Studies include:
- A CDC analysis that shows the CDC- and PEPFAR-supported Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) program is having a significant impact in reducing new HIV infections in 3 high burden districts in Malawi.
- An analysis of PEPFAR (MER) data from 2019 – 2022 that revealed adaptations CDC made to key HIV programs during the COVID pandemic, such as HIV self-testing, telemedicine, and community-based service delivery led to a substantial boost in uptake of pre-exposure prophylaxis (PrEP)–a key HIV prevention tool–among key populations in 30 countries.
- Another study highlights an HIV treatment program for female sex workers (FSW) that was led by members of this community from 2020 – 2022 — and revealed high rates of treatment adherence and viral suppression. The study underscored that engaging with the same communities we aim to reach to deliver HIV services, can dramatically improve outcomes.
At IAS 2023, DGHT experts will also present research on CDC’s data-driven approaches to identify and close gaps that prevent too many from accessing lifesaving HIV treatment and prevention services. Analyses include:
- A study on recent HIV infection (acquired within the past 12 months) in Malawi which identified several potential barriers to accessing HIV testing and prevention services in geographic areas experiencing ongoing HIV transmission.
- Another CDC analysis shows how facilities in Kenya are responding to the unique treatment needs of PLHIV using data from case-based surveillance (CBS) – a system that provides timely HIV prevention, testing, and treatment data at the individual level.
CDC Science at IAS 2023
Several of the studies highlight how CDC is addressing the critical need to reach populations that continue to be left behind, such as adolescent girls and young women and key populations which include men who have sex with men, people who inject drugs, female sex workers, and incarcerated populations. Studies include:
- A CDC analysis that found HIV diagnoses have declined dramatically in three high-burden districts in Malawi implementing the PEPFAR DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) program.
- An analysis of PEPFAR (MER) data from 2019 – 2022 that indicate adaptations CDC made to key HIV programs during the COVID-19 pandemic, such as HIV self-testing, telemedicine, and community-based service delivery has contributed to a substantial boost in uptake of pre-exposure prophylaxis (PrEP)–a key HIV prevention tool–among key populations in 30 countries.
- Another study highlights an HIV treatment program for female sex workers (FSW) that was led by members of this community from 2020 – 2022 — and revealed high rates of treatment adherence and viral suppression. The study suggests that engaging with the same communities we aim to reach to deliver HIV services, can improve outcomes.
At IAS 2023, DGHT experts will also present key findings around CDC’s data-driven approaches to identify and close gaps that prevent too many from accessing lifesaving HIV treatment and prevention services. Analyses include:
- A study on recent HIV infection (acquired within the past 12 months) in Malawi which identified several potential barriers to accessing HIV testing and prevention services in geographic areas experiencing ongoing HIV transmission.
- Another CDC analysis shows how facilities in Kenya are responding to the unique treatment needs of PLHIV using data from case-based surveillance (CBS) – a system that provides timely HIV prevention, testing, and treatment data at the individual level.
Resources
Please note that the information in the brochure may be subject to change.
Learn more about CDC’s Division of Global HIV & TB and the work we do to drive progress against two of the world’s deadliest infectious diseases.
DGHT Overview
CDC’s leadership and impact in the global response to HIV and TB
HIV Factsheet
CDC’s impact and contributions to global HIV response
TB Factsheet
CDC’s impact and contributions to the fight to end TB worldwide
Oral Sessions
DGHT Team
DGHT Team
Title
Title
Presenter
Presenter
Session
Session
HIV Prevention
Branch
HIV Prevention
Branch
Initiation of Pre-exposure Prophylaxis (PrEP) among Key
Populations in the PEPFAR-supported Countries during
2019—2022
Initiation of Pre-exposure Prophylaxis (PrEP) among Key
Populations in the PEPFAR-supported Countries during
2019—2022
Hanna Demeke
Hanna Demeke
Late Breaker
DGHT Team
DGHT Team
Title
Title
Presenter
Presenter
Session
Session
India
India
District HIV Epidemiological Profiling Using Data
Triangulation in Andhra Pradesh, India: An Evidence-Based
Initiative of decentralised data use for epidemiological
Insights & Strategic Prioritization
District HIV Epidemiological Profiling Using Data
Triangulation in Andhra Pradesh, India: An Evidence-Based
Initiative of decentralised data use for epidemiological
Insights & Strategic Prioritization
Upma Sharma
Upma Sharma
Poster Discussions
DGHT Team
DGHT Team
Title
Title
Presenter
Presenter
Session
Session
Central Asia Region
Central Asia Region
Population size estimation within a biobehavioral survey
among people who inject drugs and men who have sex
with men in the survey cities of the Kyrgyz Republic, 2021
Population size estimation within a biobehavioral survey
among people who inject drugs and men who have sex
with men in the survey cities of the Kyrgyz Republic, 2021
Nazira Usmanova
Nazira Usmanova
Epidemiology and
Surveillance Branch
Epidemiology and
Surveillance Branch
Self-Reported NCD Prevalence Among OPLWH in Southern Africa
Self-Reported NCD Prevalence Among OPLWH in Southern Africa
Christine West
Christine West
Ethiopia
Ethiopia
Integration of Human Papillomavirus Testing Into HIV Care
For Women Living With HIV
Integration of Human Papillomavirus Testing Into HIV Care
For Women Living With HIV
Ismael Ahmed
Ismael Ahmed
Global TB Branch
Global TB Branch
PEPFAR Tuberculosis Preventive Treatment Coverage and
Remaining Gaps among People Living with HIV (PLHIV)
PEPFAR Tuberculosis Preventive Treatment Coverage and
Remaining Gaps among People Living with HIV (PLHIV)
Stephanie
O’Conner
Stephanie
O’Conner
Global TB Branch
Global TB Branch
Review of Mortality Surveillance Methods
Review of Mortality Surveillance Methods
Hammad Ali
Hammad Ali
HIV Prevention
Branch
HIV Prevention
Branch
HIV Testing, Prevention, Treatment and Medicationassisted Therapy Achievements for People who Inject
Drugs in CDC/PEPFAR-supported Countries, 2021—2022
HIV Testing, Prevention, Treatment and Medicationassisted Therapy Achievements for People who Inject
Drugs in CDC/PEPFAR-supported Countries, 2021—2022
Ansley Lyn
Ansley Lyn
HIV Prevention
Branch
HIV Prevention
Branch
Implementing Social Network Strategy with Fidelity Facilitates
High HIV Testing Yield among Key Populations
Implementing Social Network Strategy with Fidelity Facilitates
High HIV Testing Yield among Key Populations
Wade Ivy, III
Wade Ivy, III
International
Laboratory Branch
International
Laboratory Branch
Independent Analytical Evaluation of the cobas® 5800
System for HIV-1 Quantitative and HIV-1/HIV-2 Qualitative
Nucleic Acid Tests
Independent Analytical Evaluation of the cobas® 5800
System for HIV-1 Quantitative and HIV-1/HIV-2 Qualitative
Nucleic Acid Tests
Shuyi Li
Shuyi Li
International
Laboratory Branch
International
Laboratory Branch
Validation of a high throughput next generation sequencing
assay for HIV drug resistance genotyping
Validation of a high throughput next generation sequencing
assay for HIV drug resistance genotyping
Du-Ping Zheng
Du-Ping Zheng
India
India
Child/adolescent-centric differentiated care to enhance
Clinical Care and Viral Load Suppression among Children and
Adolescents Living with HIV, Andhra Pradesh, India 2022
Child/adolescent-centric differentiated care to enhance
Clinical Care and Viral Load Suppression among Children and
Adolescents Living with HIV, Andhra Pradesh, India 2022
Melissa Nyendak
Melissa Nyendak
India
India
Fast-tracking treatment optimisation to address treatment
continuity through comprehensive approach and use
of digital and telehealth platforms during the COVID-19
pandemic in Andhra Pradesh, India
Fast-tracking treatment optimisation to address treatment
continuity through comprehensive approach and use
of digital and telehealth platforms during the COVID-19
pandemic in Andhra Pradesh, India
Reshu Agarwal
Reshu Agarwal
India
India
Implementation of person-centered strategies to improve
reengagement in care in Mumbai, India—2022
Implementation of person-centered strategies to improve
reengagement in care in Mumbai, India—2022
Ramesh Allam
Ramesh Allam
India
India
Improved Treatment Outcomes using Family-Centric Care
among PLHIV, Nagaland, India—2022
Improved Treatment Outcomes using Family-Centric Care
among PLHIV, Nagaland, India—2022
Ramesh Allam
Ramesh Allam
India
India
Transforming ART service delivery through key population
leadership for dismantling structural barriers to HIV care—
Experience from Andhra Pradesh, India
Transforming ART service delivery through key population
leadership for dismantling structural barriers to HIV care—
Experience from Andhra Pradesh, India
Reshu Agarwal
Reshu Agarwal
Kenya
Kenya
Compounding factors that affected viral load scale-up
and viral load coverage in Kenya, before and during the
COVID-19 pandemic
Compounding factors that affected viral load scale-up
and viral load coverage in Kenya, before and during the
COVID-19 pandemic
Daniel Kimani
Daniel Kimani
Kenya
Kenya
COVID-19 vaccination uptake among adolescents and young
people living with HIV in Kenya, 2021—2022
COVID-19 vaccination uptake among adolescents and young
people living with HIV in Kenya, 2021—2022
Immaculate Mutisya
Immaculate Mutisya
Kenya
Kenya
Improving case finding efficiency through use of machine
learning in Kenya
Improving case finding efficiency through use of machine
learning in Kenya
Margaret Ndisha
Margaret Ndisha
Kenya
Kenya
Operation triple zero (OTZ): Implementation of an assetbased approach to improve viral load suppression among
adolescents and young persons in Kenya, 2017—2021
Operation triple zero (OTZ): Implementation of an assetbased approach to improve viral load suppression among
adolescents and young persons in Kenya, 2017—2021
Immaculate Mutisya
Immaculate Mutisya
Kenya
Kenya
The progress and utility of HIV case-based surveillance in
Kenya for public health response, 2018—2022
The progress and utility of HIV case-based surveillance in
Kenya for public health response, 2018—2022
Anthony Waruru
Anthony Waruru
Kenya
Kenya
Where did they go? — An exploration of “silent” and
“non-silent” cross-facility geospatial movements of
persons on HIV treatment in Kenya, 2020—2021
Where did they go? — An exploration of “silent” and
“non-silent” cross-facility geospatial movements of
persons on HIV treatment in Kenya, 2020—2021
Anthony Waruru
Anthony Waruru
Malawi
Malawi
Access to cervical cancer screening among women living
with HIV in Malawi—Analysis of Malawi Population-based
HIV Impact Assessment (MPHIA) 2020—2021 and MPHIA
2015—2016 surveys
Access to cervical cancer screening among women living
with HIV in Malawi—Analysis of Malawi Population-based
HIV Impact Assessment (MPHIA) 2020—2021 and MPHIA
2015—2016 surveys
Laurence Gunde
Laurence Gunde
Malawi
Malawi
Comparison of new HIV diagnoses and teenage
pregnancy in DREAMS and non-DREAMS districts,
Malawi 2017—2022
Comparison of new HIV diagnoses and teenage
pregnancy in DREAMS and non-DREAMS districts,
Malawi 2017—2022
Masford Banda
Masford Banda
Malawi
Malawi
Use of Recent HIV Surveillance Data To Respond To
Ongoing HIV Transmission In Malawi
Use of Recent HIV Surveillance Data To Respond To
Ongoing HIV Transmission In Malawi
Alinune Kabaghe
Alinune Kabaghe
Nigeria
Nigeria
Deploying eHealth to facilitate community verbal autopsy for
HIV mortality surveillance: Lessons from Nigeria
Deploying eHealth to facilitate community verbal autopsy for
HIV mortality surveillance: Lessons from Nigeria
Olugbenga Asaolu
Olugbenga Asaolu
Nigeria
Nigeria
Determination of Causes of Deaths by Verbal Autopsy methods
among people living with HIV in Nigeria
Determination of Causes of Deaths by Verbal Autopsy methods
among people living with HIV in Nigeria
Olugbenga Asaolu
Olugbenga Asaolu
Tanzania
Tanzania
Assessment of COVID-19 Vaccination Uptake among People
Living with HIV in CDC-Supported Regions in Tanzania
Assessment of COVID-19 Vaccination Uptake among People
Living with HIV in CDC-Supported Regions in Tanzania
Abbas Kihame
Abbas Kihame
Tanzania
Tanzania
Assessment of the awareness of
Undetectable=Untransmissible (U=U) messaging among
people living with HIV in six regions in Tanzania, 2022
Assessment of the awareness of
Undetectable=Untransmissible (U=U) messaging among
people living with HIV in six regions in Tanzania, 2022
Coline Mahende
Coline Mahende
Tanzania
Tanzania
Correlates of experiencing continued interruption in treatment
among people living with HIV in Geita, Tanzania, 2020—2022
Correlates of experiencing continued interruption in treatment
among people living with HIV in Geita, Tanzania, 2020—2022
Alexander
Kailembo
Alexander
Kailembo
Tanzania
Tanzania
Correlates of HIV infection among Tanzanian young adults
aged 15—24 years: Evidence from the Tanzania HIV Impact
Survey 2016—2017
Correlates of HIV infection among Tanzanian young adults
aged 15—24 years: Evidence from the Tanzania HIV Impact
Survey 2016—2017
Jessica Hawk
Jessica Hawk
Tanzania
Tanzania
Integration and scale-up of HPV vaccination among an
age-eligible cohort of girls living with HIV in 11 regions
oon the mainland of Tanzania and Zanzibar
Integration and scale-up of HPV vaccination among an
age-eligible cohort of girls living with HIV in 11 regions
oon the mainland of Tanzania and Zanzibar
Daniel Magesa
Daniel Magesa
Tanzania
Tanzania
Lessons and data insights from programmatic improvements
of early infant diagnosis across CDC-supported regions in
Tanzania, 2021—2022
Lessons and data insights from programmatic improvements
of early infant diagnosis across CDC-supported regions in
Tanzania, 2021—2022
Patrick Rwehumbiza
Patrick Rwehumbiza
Tanzania
Tanzania
Prevalence and Correlates of Alcohol Drinking Among
Adult HIV+ Population: Results from the Tanzania HIV
Impact Survey 2016—2017
Prevalence and Correlates of Alcohol Drinking Among
Adult HIV+ Population: Results from the Tanzania HIV
Impact Survey 2016—2017
Jennifer Imaa
Jennifer Imaa
Tanzania
Tanzania
Time to Antiretroviral Therapy Initiation and its Associated
Factors among People Living with HIV: Results from the
Tanzania HIV Impact Survey 2016—2017
Time to Antiretroviral Therapy Initiation and its Associated
Factors among People Living with HIV: Results from the
Tanzania HIV Impact Survey 2016—2017
Abbas Kihame
Abbas Kihame
Thailand
Thailand
Economic evaluation of HIV infection recency at four health
facilities in Bangkok, Thailand
Economic evaluation of HIV infection recency at four health
facilities in Bangkok, Thailand
Sanny Northbrook
Sanny Northbrook
Thailand
Thailand
High Prevalence Of Latent Tuberculosis Infection Among
People Living with HIV in Thailand, 2022
High Prevalence Of Latent Tuberculosis Infection Among
People Living with HIV in Thailand, 2022
Rom
Luengwattanapong
Rom
Luengwattanapong
Vietnam
Vietnam
Willingness to Use and Preference for Long-Acting
Dapivirine Vaginal Ring for HIV Prevention Among Female
Sex Workers in Vietnam
Willingness to Use and Preference for Long-Acting
Dapivirine Vaginal Ring for HIV Prevention Among Female
Sex Workers in Vietnam
Yen Le
Yen Le
Zambia
Zambia
Cause of death among infants by HIV status in Zambia,
2020—2021
Cause of death among infants by HIV status in Zambia,
2020—2021
Wantula Sichembe
Wantula Sichembe
Zambia
Zambia
Closing the HIV testing gaps among children and
adolescents through Orphaned and Vulnerable Children
programs in Western Province, Zambia
Closing the HIV testing gaps among children and
adolescents through Orphaned and Vulnerable Children
programs in Western Province, Zambia
Carlos Muleya
Carlos Muleya
Zambia
Zambia
Progress towards the 95-95-95 UNAIDS targets—Zambia,
2016—2021
Progress towards the 95-95-95 UNAIDS targets—Zambia,
2016—2021
Boyd Kaliki
Boyd Kaliki
Zambia
Zambia
Weight gain among people living with HIV in Zambia
transitioning to dolutegravir-based antiretroviral regimens
containing tenofovir alafenamide versus tenofovir
disoproxil fumarate
Weight gain among people living with HIV in Zambia
transitioning to dolutegravir-based antiretroviral regimens
containing tenofovir alafenamide versus tenofovir
disoproxil fumarate
Elizabeth Heilmann
Elizabeth Heilmann
Zambia
Zambia
ZAMPHIA 2021 showed reduction in advanced HIV
disease (AHD) prevalence but further scale up of AHD
screening and management needed
ZAMPHIA 2021 showed reduction in advanced HIV
disease (AHD) prevalence but further scale up of AHD
screening and management needed
Megumi Itoh
Megumi Itoh